Irene
Gañan Gomez
Investigadora
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (3)
2017
-
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma
Cancer Cell, Vol. 32, Núm. 1, pp. 88-100.e6
2013
-
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells
Leukemia, Vol. 27, Núm. 11, pp. 2177-2186
-
Toll-like receptor alterations in myelodysplastic syndrome
Leukemia, Vol. 27, Núm. 9, pp. 1832-1840